エドガーで原本を確認する
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 Under
the Securities Exchange Act of 1934
April 2, 2024
Commission File Number: 001-36614
Alibaba Group Holding Limited
(Registrant’s name)
26/F Tower One, Times Square
1 Matheson Street
Causeway Bay
Hong Kong S.A.R.
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x Form 40-F ¨
EXHIBITS
Exhibit 99.1 – Announcement – Share Repurchase Update
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ALIBABA GROUP HOLDING LIMITED | ||
| Date: April 2, 2024 | By: | /s/ Kevin Jinwei ZHANG |
| Name: | Kevin Jinwei ZHANG | |
| Title: |
Company Secretary |
|
Exhibit 99.1
Share Repurchase Update
During the quarter ended March 31, 2024, Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), “we”) repurchased a total of 524 million ordinary shares (equivalent of 65 million ADSs) for a total of US$4.8 billion. These purchases were made in both the U.S. and Hong Kong markets under our share repurchase program. For the fiscal year ended March 31, 2024, we repurchased a total of 1,249 million ordinary shares (equivalent of 156 million ADSs) for a total of US$12.5 billion.
As of March 31, 2024, we had 19,469 million ordinary shares (equivalent of 2,434 million ADSs) outstanding, a net decrease of 520 million ordinary shares compared to December 31, 2023, or a 2.6% net reduction in our outstanding shares after accounting for shares issued under our ESOP. For the full fiscal year ended March 31, 2024, our share repurchase program resulted in a net decrease of 1,057 million ordinary shares, or a 5.1% net reduction in our outstanding shares after accounting for shares issued under our ESOP.
Historical repurchases and net reduction in total shares outstanding are set forth in the table below:
| Fiscal year ended March 31, 2023 | Fiscal year ended March 31, 2024 | ||||||||||||||||||||||||
| Three months ended | Three months ended | ||||||||||||||||||||||||
| Jun. 30, 2022 |
Sep. 30, 2022 |
Dec. 31, 2022 |
Mar. 31, 2023 |
Jun. 30, 2023 |
Sep. 30, 2023 |
Dec. 31, 2023 |
Mar. 31, 2024 |
||||||||||||||||||
| Repurchase amount (US$Bn) | $ | 3.5 | $ | 2.1 | $ | 3.3 | $ | 1.9 | $ | 3.1 | $ | 1.7 | $ | 2.9 | $ | 4.8 | |||||||||
| Shares repurchased (Mn ADSs) | 39 | 24 | 45 | 22 | 36 | 19 | 37 | 65 | |||||||||||||||||
| Outstanding shares (Mn ADSs) | 2,648 | 2,626 | 2,585 | 2,566 | 2,549 | 2,531 | 2,499 | 2,434 | |||||||||||||||||
|
Net reduction % in total shares outstanding1 |
– | – | – | (3.9 | )%2 | – | – | – | (5.1 | )% | |||||||||||||||
| 1. | Net reduction % in total shares outstanding is calculated by comparing the outstanding number of shares at the end of the fiscal year to the outstanding number of shares at the end of the prior fiscal year. |
| 2. | As of March 31, 2022, we had 21,357 million ordinary shares (equivalent of 2,670 million ADSs) outstanding. |
The remaining amount of Board authorization for our share repurchase program, which is effective through March 2027, was US$31.9 billion as of March 31, 2024.
April 2, 2024
1